Sara Di Giusto
Udine, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
High JAK2V617F allele burden in low-risk PV: an additional recommendation to start "early" cytoreduction? Results from a multicentric study.
Journal: Leukemia research
Published: July 24, 2025
Novel e4a2 BCR∷ABL1 transcript with insertion of CSE1L exons 9 and 10 in a CML patient: a case report.
Journal: Frontiers in oncology
Published: March 19, 2025
Digital PCR (dPCR) is able to anticipate the achievement of stable deep molecular response in adult chronic myeloid leukemia patients: results of the DEMONSTRATE study.
Journal: Annals of hematology
Published: September 12, 2024
Optimal timing of molecular monitoring after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia.
Journal: European journal of haematology
Published: September 23, 2022
BCR::ABL1 levels at first month after TKI discontinuation predict subsequent maintenance of treatment-free remission: A study from the "GRUPPO TRIVENETO LMC".
Journal: Cancer medicine
Published: May 28, 2022
BCL-2 Expression in AML Patients over 65 Years: Impact on Outcomes across Different Therapeutic Strategies.
Journal: Journal of clinical medicine
Published: August 27, 2021
Impact of Concomitant Aberrant CD200 and BCL2 Overexpression on Outcome of Acute Myeloid Leukemia: A Cohort Study from a Single Center
Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology
Published: February 18, 2021
ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AML.
Journal: European journal of haematology
Published: June 07, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026